Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug 14:10:345-361.
doi: 10.2147/DMSO.S100074. eCollection 2017.

Novel biomarkers for prediabetes, diabetes, and associated complications

Brenda Dorcely  1 , Karin Katz  1 , Ram Jagannathan  2 , Stephanie S Chiang  1 , Babajide Oluwadare  1 , Ira J Goldberg  1 , Michael Bergman  1
Affiliations
Review

Novel biomarkers for prediabetes, diabetes, and associated complications

Brenda Dorcely et al. Diabetes Metab Syndr Obes. .

Abstract

The number of individuals with prediabetes is expected to grow substantially and estimated to globally affect 482 million people by 2040. Therefore, effective methods for diagnosing prediabetes will be required to reduce the risk of progressing to diabetes and its complications. The current biomarkers, glycated hemoglobin (HbA1c), fructosamine, and glycated albumin have limitations including moderate sensitivity and specificity and are inaccurate in certain clinical conditions. Therefore, identification of additional biomarkers is being explored recognizing that any single biomarker will also likely have inherent limitations. Therefore, combining several biomarkers may more precisely identify those at high risk for developing prediabetes and subsequent progression to diabetes. This review describes recently identified biomarkers and their potential utility for addressing the burgeoning epidemic of dysglycemic disorders.

Keywords: biomarkers; diabetes; diabetes complications; inflammatory markers; prediabetes.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

    1. Centers for Disease Control . National Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States. Atlanta, GA: U.S. Department of Health and Human Services; 2014.
    1. International Diabetes Federation . IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.
    1. Bansal N. Prediabetes diagnosis and treatment: a review. World J Diabetes. 2015;6(2):296–303. - PMC - PubMed
    1. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 2003;46(1):3–19. - PubMed
    1. Gong Q, Gregg EW, Wang J, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia. 2011;54(2):300–307. - PubMed